Abstract
Piperacillin-tazobactam (PIP-TAZ) is an effective antimicrobial agent, indicated primarily for severe infections resulting from susceptible organisms, and it has undisputed importance within antimicrobial therapy. PIP-TAZ combinations are widely used to treat severe infections caused by Gram-negative and Gram-positive bacteria, including those that produce β-lactamases. Our study involved the development of an environmentally friendly RP-HPLC method for the simultaneous determination of TAZ and PIP. In lieu of conducting numerous experiments, an efficient method to achieve the three major parameters of chromatography—pH, flow rate, and column temperature—was optimized with the help of a Box-Behnken Design (BBD) to minimize variability. This approach streamlines the experimental process and enhances results reliability. By carefully controlling these parameters, researchers can achieve more consistent and reproducible chromatographic analyses. This research addresses the impact that these variables have on such critical responses as retention times for TAZ and PIP and their resolution. The identification of optimal conditions was based on desirable and overlay plots. The samples were dissolved in ethanol, water, and tetrabutylammonium hydroxide in the mobile phase and separated through chromatography (58.5:40:1.5, v/v/v), and the pH was maintained at 3.5 with phosphoric acid. The method used UV detection at 230 nm, an injection volume of 20 μL, and a column temperature of 30°C. It was run at a flow rate of 1.0 mL/min. It used a Symmetry Shield RP18 column for 100-micron pore size, 5-micron particle size, and 4.6-mm by 250-mm dimensions. A comparison of carbon footprint reduction index (CaFRI), analytical greenness (AGREE), analytical eco-scales, green analytical procedure index (GAPI), modified GAPI (MoGAPI), and analytical method volume intensity (AMVI), which authenticates the accuracy, precision, and robustness of the method, was made in conjunction with a lesser environmental impact.
Data availability
Data is provided within the manuscript or supplementary information files.
References
Philpott-Howard, J. et al. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. J. Antimicrob. Chemother. 52(6), 993–1000. https://doi.org/10.1093/jac/dkg463 (2003).
He, C. et al. Simultaneous determination of piperacillin, metronidazole, and tazobactam in plasma by UPLC–MS/MS and application to a pharmacokinetic study in pediatric liver transplant patients. J. Chromatogr. B Biomed. Sci. Appl. 1258, 124605. https://doi.org/10.1016/j.jchromb.2025.124605 (2025).
Chen, F. et al. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study. Transpl. Infect. Dis. 22(1), e13199. https://doi.org/10.1111/tid.13199 (2020).
Kim, D. S. et al. Asian pacific association for the study of the liver clinical practice guidelines on liver transplantation. Hepatol. Int. 18(2), 299–383. https://doi.org/10.1007/s12072-023-10629-3 (2024).
Al-Wasidi, A. S., Mohamed, M. A., Ahmed, H. A., Almalki, M. A. & Ahmed-Anwar, A. A. Comparative analysis using UPLC and UV methods for concurrent quantification of therapeutic drugs for overactive bladder: Effective approach in green and white chemistry. Results Chem. 12, 101899. https://doi.org/10.1016/j.rechem.2024.101899 (2024).
Assirey, E. A. & Mohamed, M. A. Evaluating the greenness, blueness, and whiteness of spectroscopic and UPLC techniques for the simultaneous measurement of anti-glaucoma drugs and the preservation agent. Talanta Open 10, 100367. https://doi.org/10.1016/j.talo.2024.100367 (2024).
Al‐Wasidi, A. S., Ahmed, H. A., Alshammari, M. F. A., Nafee, S. S. & Mohamed, M. A. Cutting‐edge HPLC and MCR techniques for synchronically quantifying anticholinergic drugs in the presence of C12 and C14 homologs: Robust application to green and white chemistry. Arch. Pharm 357(9), 2400256. https://doi.org/10.1002/ardp.202400256 (2024).
Nassef, H. M., Ahmed, H. A., El-Atawy, M. A., Alanazi, T. Y. A. & Mohamed, M. A. Greens assessment of RP-UPLC method for estimating triamcinolone acetonide and its degraded products compared to Box-Behnken and Six Sigma designs. Green Chem. Lett. Rev. 17, 2301315. https://doi.org/10.1080/17518253.2023.2301315 (2024).
Alsehli, B. R., Binsaleh, A. Y., Saleh, S. M., Alluhayb, A. H. & Mohamed, M. A. Environmental impact of RP-HPLC strategy for detection of selected antibiotics residues in wastewater: Evaluating of quality tools. Rev. Anal. Chem. 44, 20250086. https://doi.org/10.1515/revac-2025-0086 (2025).
Mahgoub, S. M. et al. Green and white analytical approach for parallel quantification of gabapentin and methylcobalamin in medicinal products using inventive RP-HPLC technique. Sci. Rep. 15(1), 20263. https://doi.org/10.1038/s41598-025-07056-9 (2025).
Alwaili, M. A. et al. State-of-the-art mean centering of ratio spectra and HPLC methodologies for comprehensive analysis of some dry eyes drugs: Investigation of white and green practices. Green Chem. Lett. Rev. 18(1), 2473487. https://doi.org/10.1080/17518253.2025.2473487 (2025).
Alwaili, M. A. et al. Micellar HPLC and UV methods with time programming for synchronically quantifying Gatifloxacin and its preservative in eye drops: Appraisal of ecological impact. ACS Omega 10(8), 8472–8483. https://doi.org/10.1021/acsomega.4c10508 (2025).
Pappula, N., Ameen, A. S. & Jyothi, K. Validated RP-HPLC method for simultaneous estimation of tazobactam and piperacillin in combined dosage form. Ijppr. Human 16(2), 97–105 (2019).
Veni, P. R. K., Sharmila, N., Narayana, K. J. P., Babu, B. H. & Satyanarayana, P. V. V. Simultaneous determination of piperacillin and tazobactam in pharmaceutical formulations by RP-HPLC method. J. Pharm. Res. 7(1), 127–131. https://doi.org/10.1016/j.jopr.2013.01.017 (2013).
Hussain, M. A., Taleuzzaman, M. & Saqib, M. Developing and validating a stability-indicating method for the analysis of piperacillin and tazobactam in bulk and dosage forms in human plasma using RP-HPLC. J. Chem. Health Risks 13(6), 1724–1733 (2023).
Ramalingam, P. & Rajendran, K. Detection of stability and degradation of piperacillin and tazobactam in injectables from in-patient wards and pharmacy by RP-HPLC method. Gulf Med. J. 3(1), 132–141 (2014).
Abdelkawy, K., Le, T. & Mahmoud, S. H. Simple HPLC-UV method for piperacillin/tazobactam assay in human plasma. Antibiotics 12(2), 321. https://doi.org/10.3390/antibiotics12020321 (2023).
United States pharmacopeia and national formulary (USP-NF). Piperacillin and tazobactam for injection. USP 46, NF 41. United States pharmacopeial convention, Rockville, MD, 2023
Nassef, H. M. et al. A novel Six Sigma approach and eco-friendly RP-HPLC technique for determination of pimavanserin and its degraded products: Application of Box–Behnken design. Rev. Anal. Chem. 43(1), 20230073. https://doi.org/10.1515/revac-2023-0073 (2024).
Mahgoub, S. M. et al. Eco-friendly RP-HPLC approach for simultaneously estimating the promising combination of pentoxifylline and simvastatin in therapeutic potential for breast cancer: Appraisal of greenness, whiteness, and Box–Behnken design. Green Process. Synth. 13(1), 20240139. https://doi.org/10.1515/gps-2024-0139 (2024).
Al-Kadhi, N. S., Mohamed, M. A., Ahmed, H. A. & Nassar, H. F. Facile synthesis and eco-friendly analytical methods for concurrent estimation of selected pharmaceutical drugs in their solutions: Application to quality by design, lean six sigma, and stability studies. BMC Chem. 17(1), 136. https://doi.org/10.1186/s13065-023-01028-8 (2023).
Mansour, F. R. & Nowak, P. M. Introducing the carbon footprint reduction index (CaFRI) as a software-supported tool for greener laboratories in chemical analysis. BMC Chem. 19(1), 121. https://doi.org/10.1186/s13065-025-01486-2 (2025).
Nabil, M., Ahmed, D. A., Abbas, S. S., Lotfy, H. M. & Marzouk, H. M. Green HPLC strategy for quantification of carvedilol and hydrochlorothiazide in cardiac medications with in-vitro dissolution kinetics and impurity profiling. BMC Chem. 19(1), 1–13. https://doi.org/10.1186/s13065-025-01559-2 (2025).
Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE: Analytical GREEnness metric approach and software. Anal. Chem. 92(14), 10076–10082. https://doi.org/10.1021/acs.analchem.0c01887 (2020).
Płotka-Wasylka, J. A new tool for the evaluation of the analytical procedure: Green analytical procedure index. Talanta 181, 204–209. https://doi.org/10.1016/j.talanta.2018.01.013 (2018).
Mansour, F. R., Płotka-Wasylka, J. & Locatelli, M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: Case studies and applications. Analytica 5(3), 451–457. https://doi.org/10.3390/analytica5030030 (2024).
Gałuszka, A., Migaszewski, Z. M., Konieczka, P. & Namieśnik, J. Analytical eco-scale for assessing the greenness of analytical procedures. TrAC Trends Anal. Chem. 37, 61–72. https://doi.org/10.1016/j.trac.2012.03.013 (2012).
Hartman, R., Helmy, R., Al-Sayah, M. & Welch, C. J. Analytical method volume intensity (AMVI): A green chemistry metric for HPLC methodology in the pharmaceutical industry. Green. Chem. 13(4), 934–939. https://doi.org/10.1039/C0GC00524J (2011).
ICH harmonized tripartite guideline. Curr. Step. 4: 1–17. (2005).
Acknowledgements
Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2026R35), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Funding
The authors declare that no funding was received for this work.
Author information
Authors and Affiliations
Contributions
Asma S. Al‐Wasidi: Conceptualization, Methodology, Writing – Review & Editing. Jumana A. Sanari: Data Curation, Validation, Visualization. Fahad M. Alminderej: Supervision, Formal Analysis, Funding Acquisition, . Sayed M. Saleh: Investigation, Resources, Writing – Final Draft. Hoda A. Ahmed: Software, Writing – Review & Editing. Mahmoud A. Mohamed: Method Development, Experimental Work, Project Administration, Writing – Original Draft.
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Al‐Wasidi, A.S., Sanari, J.A., Alminderej, F.M. et al. Eco-optimized RP-HPLC method for chiral tazobactam and piperacillin drugs: integration with Box–Behnken design and multi-sustainability tools. Sci Rep (2026). https://doi.org/10.1038/s41598-026-44942-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-44942-2
